Monograph Capital
Overview
Monograph Capital is a venture firm focused on life sciences. With a dedicated emphasis on the life sciences sector, Monograph Capital invests in innovative companies and technologies that aim to advance healthcare and biotechnology. The firm supports early-stage ventures as well as growth-stage companies, providing critical capital, strategic guidance, and industry expertise to drive their development and success . Monograph Capital's investments span across biotech, pharmaceuticals, medical devices, and other areas within the life sciences field, aiming to contribute to breakthrough discoveries, therapies, and medical advancements . Through its strategic investments, Monograph Capital plays a crucial role in accelerating innovation and improving health outcomes globally .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Ollin Biosciences | Jun 2026 | Series B | Co-investor |
| AviadoBio | Dec 2021 | Series A | Lead |
| Nocion Therapeutics | Jan 2026 | Series B Extension | Lead |
| ODAIA | May 2023 | Series B | Lead |
| Elevara Medicines | Oct 2025 | Series A | Co-investor |
For institutional investors. Book with your work email.
Key People
Charles Conn
Co-founder and Partner, Monograph Capital
Jo T.
EA to Founder and Partner (Start Up Life Science VC)
Matt McAviney
Partner
Tim Funnell
Partner
Bonnie van Wilgenburg
Principal
Freddie Dear
Principal
Jaideep Dudani
Principal
Charlie Zhou
Investment Manager
Melisa Guven
Investment Manager
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Monograph Capital based?
Monograph Capital is headquartered in London, England, United Kingdom.
When was Monograph Capital founded?
Monograph Capital was founded in 2021.
How many portfolio companies does Monograph Capital have?
Monograph Capital has 15 portfolio companies in Caplight's dataset.
What are some companies in Monograph Capital's portfolio?
Portfolio companies visible on Caplight include Ollin Biosciences, AviadoBio, Nocion Therapeutics, ODAIA, Elevara Medicines.
What was Monograph Capital's most recent investment shown here?
Monograph Capital's most recent investment in this portfolio sample was in Ollin Biosciences in 2026.
What sectors does Monograph Capital focus on?
Monograph Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Monograph Capital focus on?
Monograph Capital typically invests at the Early stage.
What is Monograph Capital's AUM?
Monograph Capital's assets under management are estimated between $50.0M and $100.0M.